Distribution of adults (between 18 and 50 years) by serological status for Yellow Fever 30–45 days after vaccination, stratified by pre-vaccine serological status (neutralizing antibodies) for dengue and Zika.

Distribution of adults (between 18 and 50 years) by serological status for Yellow Fever 30–45 days after vaccination, stratified by pre-vaccine serological status (neutralizing antibodies) for dengue and Zika.

<p>Distribution of adults (between 18 and 50 years) by serological status for Yellow Fever 30–45 days after vaccination, stratified by pre-vaccine serological status (neutralizing antibodies) for dengue and Zika.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Camylla Veloso Valença Saucha (21030022) (author)
مؤلفون آخرون:	Maria de Lourdes de Sousa Maia (14120604) (author), Eduardo Sérgio Soares Sousa (10401782) (author), Patrícia Mouta Nunes de Oliveira (21030025) (author), Janaína Reis Xavier (11087253) (author), Thalita da Matta de Castro (21030028) (author), Robson Leite de Souza Cruz (21030031) (author), Waleska Dias Schwarcz (11768222) (author), Renata Carvalho Pereira (6619814) (author), Adriana de Souza Azevedo (11768219) (author), Ana Maria Bispo de Filippis (8193666) (author), Clara Lucy de Vasconcellos Ferroco (21030034) (author), Geovanna de Lima Cunha Pizzini (21030037) (author), Ricardo Cristiano de Souza Brum (21030040) (author), Leonardo Secundino (21030043) (author), Maria de Fátima de Sousa Andrade (21030046) (author), Raquel de Vasconcellos Carvalhaes de Oliveira (14341669) (author), Marisol Simões (5348882) (author), José Cerbino-Neto (6720542) (author), Olindo Assis Martins-Filho (6864623) (author), Ana Carolina Campi-Azevedo (6864584) (author), Sheila Maria Barbosa de Lima (6864602) (author), Luiz Antonio Bastos Camacho (6864611) (author)
منشور في:	2025
الموضوعات:	Medicine Microbiology Biotechnology Immunology Cancer Science Policy Infectious Diseases Virology Computational Biology world health organization provide sufficient protection aedes aegypti </ area without wild yellow fever transmission high vector density div >< p dengue neutralizing antibodies adults aged 18 17dd strain vaccine yf antibody titers uncontrolled cohort study yellow fever endemic area cohort study antibody titration yf vaccine three municipalities single dose sectional studies risk areas reaching 99 prior dengue primary target phase iv one year observed across northeastern brazil inversely associated induced immunity high incidence following assays data support considerable reduction brazil occurs booster doses booster dose blood samples 50 years 4 years
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Distribution of children (between 9 months and 4 years) by serological status for yellow fever 30–45 days after vaccination, stratified by pre-vaccine serological status (neutralizing antibodies) for dengue and Zika.
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Sociodemographic and pre-vaccination status for yellow fever, dengue and Zika by age group.
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Diagram of study participants and blood samples pre-vaccine, 30–45 days and 1 year after vaccination.
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Percentage and 95% confidence intervals of yellow fever seroconversion 30–45 days and 1 year after vaccination by age range.
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Cutoff points obtained by segmented models of the outcome neutralizing antibody titer for yellow fever 30–45 days after vaccination.
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Geometric means and 95% confidence intervals of yellow fever antibody titers (reciprocal of dilution) 30–45 days and 1 year after vaccination by age range.
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Logistic models to high<sup>*</sup> neutralizing antibody titer for yellow fever 30–45 days after vaccination in adults (between 18 and 50 years) (n = 240).
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Logistic models to high<sup>*</sup> neutralizing antibody titer for yellow fever 30–45 days after vaccination in children (between 9 months and 4 years) (n = 339).
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Logistic models to high<sup>*</sup> neutralizing antibody titer for yellow fever 30–45 days after vaccination in adults (between 18 and 50 years) (n = 1,504).
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

Logistic models to high<sup>*</sup> neutralizing antibody titer for yellow fever 30–45 days after vaccination in children (between 9 months and 4 years) (n = 2,328).
حسب: Camylla Veloso Valença Saucha (21030022)
منشور في: (2025)

The impact of administration of emergency vaccine with different vaccination rates on the incidence and cumulative cases under RCP 8.5 scenario.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

The impact of a (hypothetical) administration of emergency vaccine with different vaccination rates on the incidence and cumulative cases during the 2017/2018 outbreak.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

The impact of the mosquito-to-human transmission rate and the emergency vaccination rate on the reduction of cumulative infections (both symptomatic and asymptomatic) during the first 15 weeks of the epidemic in the study region, under the RCP 8.5 scenario, assuming a constant emergency vaccination rate throughout the outbreak.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

The equivalence between reducing the mosquito-to-human transmission rate and administrating emergency vaccine in terms of reducing the cumulative (both symptomatic and asymptomatic) infections of the first 15 weeks from epidemic outbreak in the study region under the RCP 8.5 scenario.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

Biological explanations and values of the model parameters.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

Model variable descriptions and initial conditions: Brazil 2017/2018 outbreak.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

The basic human infection reproduction number in the study region under different temperatures and mosquito-to-human transmission rates.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

The heatmap of the basic human infection reproduction number in the study region by varying the average temperature and average rainfall in the range under different climate projection scenarios.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

Impact of temperature and rainfall on cumulative symptomatic infections in the study region under different RCP scenarios, over the course of the first 15 weeks of the outbreak.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

Impact of rainfall on the cumulative cases in the study region, where average temperature is held constant at a value of approximately 24 <sup>∘</sup>C.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

Impact of temperature on the cumulative cases in the study region, where average rainfall is held constant at a value of approximately 28 mm.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

Simulated curve of symptomatic infectious humans (red), from the fitted YF model, compared to the incidence data from the 2017/2018 outbreak (blue dots).
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

An illustration of the compartmental model for the YF transmission dynamics: Yellow compartments represent the infected classes (including the exposed classes for human and mosquitoes), while the diamond-shaped compartments are for the infectious classes.
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

S1 Code - Risk assessment and mitigation evaluation of future yellow fever outbreaks under different climate scenarios: Insight from a case study of Brazil
حسب: Tedi Ramaj (22446827)
منشور في: (2025)

Table of parameters.
حسب: Keith Fraser (1868587)
منشور في: (2024)

Fig 7 -
حسب: Keith Fraser (1868587)
منشور في: (2024)

Fig 6 -
حسب: Keith Fraser (1868587)
منشور في: (2024)

Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected South American countries.
حسب: Keith Fraser (1868587)
منشور في: (2024)

Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected African countries.
حسب: Keith Fraser (1868587)
منشور في: (2024)

Graphs showing reproduction of selected South American annual case (a) and death (b) data using 1000 parameter sets drawn from post-burn-in distribution obtained from 4 Markov chains.
حسب: Keith Fraser (1868587)
منشور في: (2024)

Modelled seroprevalence estimates (coloured regions) compared with real data (black).
حسب: Keith Fraser (1868587)
منشور في: (2024)

Diagram of SEIRV model of yellow fever transmission in humans showing zoonotic transfer from the sylvatic non-human primate reservoir (mediated by the λ<sub><i>S</i></sub> parameter) and transmission from infectious humans (mediated by the <i>R</i><sub>0</sub> parameter).
حسب: Keith Fraser (1868587)
منشور في: (2024)

Data Sheet 1_Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses.docx
حسب: Beatriz L. L. Caetano (21981908)
منشور في: (2025)

Data Sheet 1_Improved antibody breadth with an extended primary dose interval of COVID-19 vaccine is overcome by boosters.docx
حسب: Jessica I. Ahmed (20945066)
منشور في: (2025)

Incremental cost effectiveness ratio analysis (50% reduction of vaccination cost).
حسب: Chayanit Mahasing (19688403)
منشور في: (2024)

Table 1_Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production.docx
حسب: Beatriz Castro-Robles (20506802)
منشور في: (2025)

Genetic differences between YFV-Asibi isolates and YFV-17D substrains.
حسب: Xueer Qiu (21865322)
منشور في: (2025)

The NS2B mutations I37L and I109L cooperate to attenuate rHA7-Asibi.
حسب: Xueer Qiu (21865322)
منشور في: (2025)

The NS2B-I109L mutation attenuates rHA1-Asibi.
حسب: Xueer Qiu (21865322)
منشور في: (2025)

Attenuation determinant(s) of 17D map to NS2B.
حسب: Xueer Qiu (21865322)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_sgs42tmdti88haibda61qq3msp